Guangdong taienkang Pharmaceutical Co., Ltd
Initial public offering and listing on GEM
Announcement of issuance results
Sponsor (lead underwriter): Guotai Junan Securities Co.Ltd(601211)
hot tip
The application of Guangdong taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as “the issuer” or “the company”) for the initial public offering of 59.1 million RMB common shares (A shares) (hereinafter referred to as “this offering”) has been examined and approved by the venture board listing committee of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been approved to register by the China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2022] No. 203). The sponsor (lead underwriter) of this offering is Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as ” Guotai Junan Securities Co.Ltd(601211) ” or “sponsor (lead underwriter)”). The issuer’s shares are abbreviated as “tynkon” and the stock code is “301263”.
The issuer and the sponsor (lead underwriter) Guotai Junan Securities Co.Ltd(601211) negotiated and determined that the number of shares to be issued this time is 59.1 million, and the price of this issuance is 19.93 yuan / share.
The issuing price of this offering does not exceed the median and weighted average of the offline investors’ quotation after excluding the highest quotation, as well as the Securities Investment Fund (hereinafter referred to as “public fund”), the National Social Security Fund (hereinafter referred to as “social security fund”), the basic old-age insurance fund (hereinafter referred to as “pension”) established through public offering after excluding the highest quotation The enterprise annuity fund (hereinafter referred to as “enterprise annuity fund”) established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund (hereinafter referred to as “insurance fund”) in accordance with the measures for the administration of the use of insurance funds and other provisions, whichever is lower, is 199307 yuan / share. According to item (IV) of Article 39 of the detailed rules for the implementation of the issuance and underwriting of initial public offering of securities on the growth enterprise market of Shenzhen Stock Exchange (revised in 2021) (SZS [2021] No. 919), the relevant subsidiary of the sponsor Guotai Junan Securities Co.Ltd(601211) csyu Investment Co., Ltd. (hereinafter referred to as “csyu investment”) does not need to participate in this strategic placement, and all the shares initially invested by csyu investment will be transferred back to offline issuance.
According to the final price, the final strategic placement quantity of the issuer’s special asset management plan for senior management and core employees Guotai Junan Securities Co.Ltd(601211) Junxiang gem taienkang No. 1 strategic placement collective asset management plan (hereinafter referred to as “taienkang No. 1 asset management plan”) is 5435022 shares, accounting for 9.20% of the Issuance quantity.
The initial strategic allotment of this issuance was 8.865 million shares, accounting for 15.00% of this issuance. The final number of strategic placements was 5435022 million shares, accounting for 9.20% of the number of shares issued this time. The difference between the initial strategic placement and the final strategic placement of 3429978 million shares will be transferred back to offline issuance.
Finally, the issuance is carried out in a combination of directional placement to strategic investors, offline inquiry placement to qualified investors and online pricing issuance to social public investors holding non restricted A-share shares in Shenzhen market or the market value of non restricted depositary receipts.
After the callback of strategic placement and before the launch of online and offline callback mechanism, the number of offline issuance was 38594478 shares, accounting for 71.92% of the number issued after deducting the final number of strategic placement; The number of shares issued online was 150705 million, accounting for 28.08% of the number issued after deducting the final strategic placement. According to the callback mechanism announced in the announcement of Guangdong taienkang Pharmaceutical Co., Ltd. on its initial public offering and listing on the gem (hereinafter referred to as the “issuance announcement”), since the initial effective subscription multiple on the Internet is 798762052 times, higher than 100 times, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism and callback 10733000 million shares from offline to online. After the call back, the final number of offline shares issued was 27861478, accounting for 51.92% of the total issued after deducting the final strategic placement; The final number of shares issued online was 25.835 million, accounting for 48.08% of the total issued after deducting the final strategic placement. After the call back, the final winning rate of this online pricing issuance is 00214354958%, and the subscription multiple is 466515918 times.
The online and offline subscription and payment work of this offering has been completed on March 22, 2022 (T + 2). The details are as follows:
1、 Statistics of new share subscription
According to the data provided by Shenzhen Stock Exchange and Shenzhen Branch of China depository and Clearing Corporation Limited (hereinafter referred to as “Shenzhen Branch of China Clearing”), the sponsor (lead underwriter) made statistics on the strategic placement and the subscription of new shares issued online and offline. The results are as follows:
(I) strategic placement
Based on the preliminary inquiry results, the issuer and the recommendation institution (lead underwriter) negotiated and determined that the offering price is 19.93 yuan / share. The issuing price of this offering shall not exceed the lower of the median and weighted average of offline investors’ quotation after excluding the highest quotation and the median and weighted average of public funds, social security funds, pensions, enterprise annuity funds and insurance funds after excluding the highest quotation. Therefore, the relevant subsidiary of the sponsor, securities margin investment, does not need to participate in the strategic placement of this issuance, and the number of shares initially participated in the follow-up investment of securities margin investment will be fully reversed
To offline distribution. According to the final price, the final strategic placement quantity of tynkang No. 1 asset management plan is 54350220 shares, accounting for 9.20% of the issuance quantity.
As of March 15, 2022 (T-3), strategic investors have paid their subscription funds in full and on time. first
If the initial payment amount exceeds the corresponding amount of the final allocated shares, the sponsor (lead underwriter) will
Before March 24, 2022 (T + 4), it shall be returned according to the original path of payment. According to the relevant agreements in the strategic placement agreement signed by the issuer and strategic investors, the strategic placement results of this issuance are determined as follows:
Serial number name of strategic investor number of allocated shares (shares) amount allocated (yuan) sales restriction period
1 taienkang No. 1 asset management plan 543502210831998846 12 months
(II) online subscription of new shares
1. Number of shares subscribed by online investors (shares): 25711806
2. Subscription amount paid by online investors (yuan): 51243629358
3. Number of online investors giving up subscription (shares): 91694
4. Subscription amount abandoned by online investors (yuan): 182746142
(III) offline subscription of new shares
1. Number of shares subscribed by offline investors (shares): 27861478
2. Subscription amount paid by offline investors (yuan): 55527925654
3. Number of offline investors giving up subscription (shares): 0
4. Subscription amount abandoned by offline investors (yuan): 0
2、 Offline proportional restriction
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing.
That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
In this offering, the number of shares whose offline proportion is restricted for six months is 2789785, accounting for about 10.01% of the total offline issuance and 4.72% of the total public offering.
3、 Underwriting by the recommendation institution (lead underwriter)
The number of shares abandoned by online and offline investors is underwritten by the sponsor (lead underwriter). The number of shares underwritten by the sponsor (lead underwriter) this time is 91694 shares, the underwriting amount is 182746142 yuan, and the number of underwritten shares accounts for 0.16% of the total issued number.
On March 24, 2022 (T + 4), the sponsor (lead underwriter) transferred the underwriting funds and the funds paid and subscribed by online and offline investors after deducting the sponsor underwriting fee to the issuer. The issuer submitted an application for share registration to CSDCC Shenzhen Branch and registered the underwriting shares to the securities account designated by the sponsor (lead underwriter).
4、 Contact information of sponsor (lead underwriter)
If online and offline investors have any questions about the placement results announced in this announcement, please contact the sponsor (lead underwriter) of this offering. The specific contact information is as follows:
Tel.: 02138676888
Contact: capital market department
Issuer: sponsor (lead underwriter) of Guangdong taienkang Pharmaceutical Co., Ltd.: Guotai Junan Securities Co.Ltd(601211) March 24, 2022
(there is no text on this page, which is the seal page of the announcement on the results of initial public offering and listing on the gem of Guangdong taienkang Pharmaceutical Co., Ltd.)
Issuer: Guangdong taienkang Pharmaceutical Co., Ltd
(there is no text on this page, which is the seal page of the announcement on the results of initial public offering and listing on the gem of Guangdong taienkang Pharmaceutical Co., Ltd.)
Sponsor (lead underwriter): Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
